Chelsea Counsel Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $344K | Sell |
2,840
-420
| -13% | -$48.5K | 0.15% | 82 |
|
|
2025
Q4 | $346K | Sell |
3,260
-250
| -7% | -$23.5K | 0.15% | 85 |
|
|
2025
Q3 | $297K | Sell |
3,510
-340
| -9% | -$28K | 0.13% | 92 |
|
|
2025
Q2 | $308K | Sell |
3,850
-15,570
| -80% | -$1.24M | 0.15% | 87 |
|
|
2025
Q1 | $1.76M | Hold |
19,420
| – | – | 0.96% | 28 |
|
|
2024
Q4 | $1.95M | Sell |
19,420
-3,255
| -14% | -$336K | 1.01% | 27 |
|
|
2024
Q3 | $2.59M | Sell |
22,675
-90
| -0.4% | -$10.7K | 1.28% | 19 |
|
|
2024
Q2 | $2.84M | Sell |
22,765
-56
| -0.2% | -$7.21K | 1.42% | 18 |
|
|
2024
Q1 | $3.03M | Sell |
22,821
-2,400
| -10% | -$296K | 1.72% | 16 |
|
|
2023
Q4 | $2.77M | Sell |
25,221
-4,000
| -14% | -$415K | 1.47% | 20 |
|
|
2023
Q3 | $3.03M | Hold |
29,221
| – | – | 1.56% | 16 |
|
|
2023
Q2 | $3.39M | Hold |
29,221
| – | – | 1.67% | 15 |
|
|
2023
Q1 | $3.13M | Buy |
29,221
+100
| +0.3% | +$10.8K | 1.52% | 18 |
|
|
2022
Q4 | $3.25M | Buy |
29,121
+500
| +2% | +$51.1K | 1.62% | 16 |
|
|
2022
Q3 | $2.46M | Sell |
28,621
-5,569
| -16% | -$497K | 1.52% | 20 |
|
|
2022
Q2 | $3.12M | Sell |
34,190
-40
| -0.1% | -$3.55K | 1.6% | 18 |
|
|
2022
Q1 | $2.81M | Sell |
34,230
-127
| -0.4% | -$10K | 1.24% | 26 |
|
|
2021
Q4 | $2.63M | Hold |
34,357
| – | – | 1.14% | 25 |
|
|
2021
Q3 | $2.58M | Sell |
34,357
-240
| -0.7% | -$18.3K | 1.17% | 26 |
|
|
2021
Q2 | $2.69M | Sell |
34,597
-1,661
| -5% | -$124K | 1.24% | 26 |
|
|
2021
Q1 | $2.67M | Sell |
36,258
-104
| -0.3% | -$7.67K | 1.32% | 25 |
|
|
2020
Q4 | $2.84M | Sell |
36,362
-748
| -2% | -$57.2K | 1.46% | 23 |
|
|
2020
Q3 | $2.94M | Sell |
37,110
-1
| -0% | -$78 | 1.74% | 19 |
|
|
2020
Q2 | $2.74M | Buy |
37,111
+1,823
| +5% | +$137K | 1.69% | 19 |
|
|
2020
Q1 | $2.59M | Buy |
35,288
+3,389
| +11% | +$266K | 2.03% | 17 |
|
|
2019
Q4 | $2.77M | Buy |
31,899
+1,378
| +5% | +$113K | 1.68% | 20 |
|
|
2019
Q3 | $2.45M | Sell |
30,521
-8,463
| -22% | -$678K | 1.48% | 23 |
|
|
2019
Q2 | $3.12M | Buy |
38,984
+868
| +2% | +$66.5K | 1.67% | 22 |
|
|
2019
Q1 | $3.02M | Hold |
38,116
| – | – | 1.63% | 21 |
|
|
2018
Q4 | $2.78M | Hold |
38,116
| – | – | 1.69% | 21 |
|
|
2018
Q3 | $2.58M | Sell |
38,116
-841
| -2% | -$53.6K | 1.34% | 24 |
|
|
2018
Q2 | $2.26M | Buy |
38,957
+25,466
| +189% | +$1.44M | 1.34% | 25 |
|
|
2018
Q1 | $701K | Hold |
13,491
| – | – | 0.45% | 43 |
|
|
2017
Q4 | $724K | Hold |
13,491
| – | – | 0.39% | 52 |
|
|
2017
Q3 | $824K | Buy |
13,491
+3
| +0% | +$182 | 0.41% | 52 |
|
|
2017
Q2 | $825K | Buy |
13,488
+9
| +0.1% | +$548 | 0.43% | 51 |
|
|
2017
Q1 | $817K | Buy |
13,479
+3
| +0% | +$182 | 0.42% | 50 |
|
|
2016
Q4 | $757K | Buy |
13,476
+132
| +1% | +$7.72K | 0.4% | 48 |
|
|
2016
Q3 | $795K | Buy |
13,344
+260
| +2% | +$15.2K | 0.41% | 46 |
|
|
2016
Q2 | $719K | Hold |
13,084
| – | – | 0.32% | 54 |
|
|
2016
Q1 | $661K | Hold |
13,084
| – | – | 0.21% | 61 |
|
|
2015
Q4 | $659K | Sell |
13,084
-103,262
| -89% | -$5.21M | 0.2% | 63 |
|
|
2015
Q3 | $5.48M | Buy |
116,346
+21,888
| +23% | +$1.16M | 1.31% | 27 |
|
|
2015
Q2 | $5.13M | Sell |
94,458
-1,247
| -1% | -$69.9K | 1.15% | 29 |
|
|
2015
Q1 | $5.25M | Sell |
95,705
-158
| -0.2% | -$8.95K | 1.13% | 33 |
|
|
2014
Q4 | $5.2M | Hold |
95,863
| – | – | 1.07% | 33 |
|
|
2014
Q3 | $5.42M | Buy |
95,863
+2,021
| +2% | +$113K | 1.08% | 34 |
|
|
2014
Q2 | $5.18M | Buy |
93,842
+838
| +0.9% | +$45.7K | 1.01% | 35 |
|
|
2014
Q1 | $5.04M | Sell |
93,004
-10,794
| -10% | -$559K | 1.02% | 37 |
|
|
2013
Q4 | $4.96M | Hold |
103,798
| – | – | 1.17% | 37 |
|
|
2013
Q3 | $4.71M | Hold |
103,798
| – | – | 0.98% | 40 |
|
|
2013
Q2 | $4.6M | Buy |
+103,798
| New | +$4.64M | 1.21% | 37 |
|
Other funds holding MRK
VCM
VPM
Chelsea Counsel Company's MRK Position: Q1 2026 in Review
Chelsea Counsel Company reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $48.5K and leaving 2,840 shares worth $344K. The position accounts for 0.15% of the portfolio, ranked #82.
Chelsea Counsel Company first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.48M in Q3 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Chelsea Counsel Company held 2,840 shares of Merck worth $344K as of Q1 2026.
- Chelsea Counsel Company sold 420 Merck shares in Q1 2026, an estimated $48.5K.
- Merck made up 0.15% of Chelsea Counsel Company's portfolio in Q1 2026, its #82 holding.
- Chelsea Counsel Company first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Chelsea Counsel Company's Merck position peaked at $5.48M in Q3 2015.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.